Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait

Environmental Research

Volumn 133, Issue , 2014, Pages 20-26

  Ahmad, Suhail ^a   Khan, Ziauddin ^a   Hagen, Ferry ^b   Meis, Jacques F ^b,c  

^a KUWAIT UNIVERSITY   (Kuwait)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aspergillus fumigatus; Environmental isolation; Microsatellite analysis; Triazole resistance detection

Indexed keywords

ITRACONAZOLE; MICROSATELLITE DNA; POSACONAZOLE; VORICONAZOLE; WATER;

ATMOSPHERIC POLLUTION; ENVIRONMENTAL FATE; FUNGICIDE; FUNGUS; GENETIC MARKER; MOLECULAR ANALYSIS; MUTATION; PESTICIDE RESISTANCE; PHENOTYPE; POLLUTION EXPOSURE;

ALLELE; AMBIENT AIR; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; BROTH DILUTION; CODON; COTTON; CYP51A GENE; EPSILOMETER TEST; FUNGAL GENE; FUNGUS CULTURE; FUNGUS ISOLATION; FUNGUS MUTATION; GENE; GENE LOCUS; GENE MUTATION; HOSPITAL; KUWAIT; MALT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TANDEM REPEAT;

ARABIAN PENINSULA; KUWAIT [MIDDLE EAST];

ASPERGILLUS FUMIGATUS; ENVIRONMENTAL ISOLATION; MICROSATELLITE ANALYSIS; TRIAZOLE RESISTANCE DETECTION;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CYTOCHROME P-450 ENZYME SYSTEM; DESERT CLIMATE; DRUG RESISTANCE, MULTIPLE, FUNGAL; ENVIRONMENTAL MONITORING; FUNGAL PROTEINS; HOSPITALS; KUWAIT; MICROSATELLITE REPEATS; MUTATION; TRIAZOLES;

EID: 84901813571     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2014.05.009     Document Type: Article

References (40)

1. Al-Wathiqi F., Ahmad S., Khan Z.U. Molecular characterization and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait. BMC Infect. Dis. 2013, 13:126.
2. Arendrup M.C., Bille J., Dannaoui E., Ruhnke M., Heussel C.P., Kibbler C. ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia. Bone Marrow Transplant. 2012, 47:1030-1045.
3. Ariza-Heredia E.J., Kontoyiannis D.P. Our recommendations for avoiding exposure to fungi outside the hospital for patients with haematological cancers. Mycoses 2014, 57:336-341.
4. 34 /L98H mutations in the cyp51A gene in Iran. Mycoses 2013, 56:659-663.
5. Bader O., Weig M., Reichard U., Lugert R., Kuhns M., Christner M., Held J., Peter S., Schumacher U., Buchheidt D., Tintelnot K., Groß U., MykoLabNet-D Partners cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. Antimicrob. Agents Chemother. 2013, 57:3513-3517.
6. Burgel P.R., Baixench M.T., Amsellem M., Audureau E., Chapron J., Kanaan R., Honoré I., Dupouy-Camet J., Dusser D., Klaassen C.H., Meis J.F., Hubert D., Paugam A. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob. Agents Chemother. 2012, 56:869-874.
7. 34/L98H azole resistance mechanism. J. Clin. Microbiol. 2012, 50:2674-2680.
8. Camps S.M.T., van der Linden J.W.M., Li Y., Kuijper E.J., van Dissel J.T., Verweij P.E., Melchers W.J. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob. Agents Chemother. 2012, 56:10-16.
9. 34/L98H mutations in the cyp51A gene in India. J. Antimicrob. Chemother. 2012, 67:362-366.
10. 34/L98H mutations in the cyp51A gene in India. PLoS One 2012, 7:e52871.
11. Chowdhary A., Kathuria S., Xu J., Meis J.F. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog. 2013, 9:e1003633.
12. Chowdhary A., Sharma C., Kathuria S., Hagen F., Meis J.F. Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India. J. Antimicrob. Chemother. 2014, 69:555-557.
13. Clinical and Laboratory Standard Institute (2008, Reference method for broth dilution antifungal susceptibility testing of filamentous fungi-second edition: approved standard M38-A2, CLSI, Wayne, PA.
14. Denning D.W., Bowyer P. Voriconazole resistance in Aspergillus fumigatus: should we be concerned?. Clin. Infect. Dis. 2013, 57:521-523.
15. Denning D.W., Park S., Lass-Florl C., Fraczek M.G., Kirwan M., Gore R., Smith J., Bueid A., Moore C.B., Bowyer P., Perlin D.S. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin. Infect. Dis. 2011, 52:1123-1129.
16. de Valk H.A., Meis J.F., Curfs I.M., Muehlethaler K., Mouton J.W., Klaassen C.H. Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates. J. Clin. Microbiol. 2005, 43:4112-4120.
17. Fischer J., van Koningsbruggen-Rietschel S., Rietschel E., Vehreschild M.J., Wisplinghoff H., Krönke M., Hamprecht A. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients. J. Antimicrob. Chemother. 2014, (in press). 10.1093/jac/dku009.
18. Hamprecht A., Buchheidt D., Vehreschild J.J., Cornely O.A., Spiess B., Plum G., Halbsguth T.V., Kutsch N., Stippel D., Kahl P., Persigehl T., Steinbach A., Bos B., Hallek M., Vehreschild M.J. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany. Euro Surveill. 2012, 17:20262.
19. Howard S.J., Cesar D., Anderson M.J., Albarrag A., Fisher M.C., Pasqualotto A.C., Laverdiere M., Arendrup M.C., Perlin D.S., Denning D.W. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg. Infect. Dis. 2009, 15:1068-1076.
20. Khan Z.U., Ahmad S., Theyyathel A.M. Detection of Aspergillus fumigatus-specific DNA, (1-3)-β-d-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats. Mycoses 2008, 51:129-135.
21. Klaassen C.H., de Valk H.A., Curfs-Breuker I.M., Meis J.F. Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands. J. Antimicrob. Chemother. 2010, 65:901-905.
22. Kontoyiannis D.P., Marr K.A., Park B.J., Alexander B.D., Anaissie E.J., Walsh T.J., Ito J., Andes D.R., Baddley J.W., Brown J.M., Brumble L.M., Freifeld A.G., Hadley S., Herwaldt L.A., Kauffman C.A., Knapp K., Lyon G.M., Morrison V.A., Papanicolaou G., Patterson T.F., Perl T.M., Schuster M.G., Walker R., Wannemuehler K.A., Wingard J.R., Chiller T.M., Pappas P.G. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin. Infect. Dis. 2010, 50:1091-1100.
23. Lockhart S.R., Frade J.P., Etienne K.A., Pfaller M.A., Diekema D.J., Balajee S.A. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob. Agents Chemother. 2011, 55:4465-4468.
24. Mavridou E., Meletiadis J., Jancura P., Abbas S., Arendrup M.C., Melchers W.J., Heskes T., Mouton J.W., Verweij P.E. Composite survival index to compare virulence changes in azole-resistant Aspergillus fumigatus clinical isolates. PLoS One 2013, 8:e72280.
25. Mellado E., Garcia-Effron G., Alcázar-Fuoli L., Melchers W.J., Verweij P.E., Cuenca-Estrella M., Rodriguez-Tudela J.L. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob. Agents Chemother. 2007, 51:1897-1904.
26. Mikolajewska A., Schwartz S., Ruhnke M. Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy. Mycoses 2012, 55:2-16.
27. Mortensen K.L., Mellado E., Lass-Flörl C., Rodriguez-Tudela J.L., Johansen H.K., Arendrup M.C. Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain. Antimicrob. Agents Chemother. 2010, 54:4545-4549.
28. Pfaller M., Boyken L., Hollis R., Kroeger J., Messer S., Tendolkar S., Diekema D. Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles. J. Clin. Microbiol. 2011, 49:586-590.
29. Rath P.M., Buchheidt D., Spiess B., Arfanis E., Buer J., Steinmann J. First reported case of azole-resistant Aspergillus fumigatus due to the TR/L98H mutation in Germany. Antimicrob. Agents Chemother. 2012, 56:6060-6061.
30. Rocchi S., Daguindau E., Grenouillet F., Deconinck E., Bellanger A.P., Garcia-Hermoso D., Bretagne S., Reboux G., Millon L. Azole-resistant Aspergillus fumigatus isolate with the TR34/L98H mutation in both a fungicide-sprayed field and the lung of a hematopoietic stem cell transplant recipient with invasive aspergillosis. J. Clin. Microbiol. 2014, 52:1724-1726.
31. Samson R.A., Hong S., Peterson S.W., Frisvad J.C., Varga J. Polyphasic taxonomy of Aspergillus section Fumigati and its teleomorph Neosartorya. Stud. Mycol. 2007, 59:147-203.
32. Snelders E., van der Lee H.A.L., Kuijpers J., Rijs A.J., Varga J., Samson R.A., Mellado E., Donders A.R., Melchers W.J., Verweij P.E. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008, 5:e219.
33. Snelders E., Huis In 't Veld R.A., Rijs A.J., Kema G.H., Melchers W.J., Verweij P.E. Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl. Environ. Microbiol. 2009, 75:4053-4057.
34. Spiess B., Seifarth W., Merker N., Howard S.J., Reinwald M., Dietz A., Hofmann W.K., Buchheidt D. Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients. Antimicrob. Agents Chemother. 2012, 56:3905-3910.
35. Verweij P.E., Te Dorsthorst D.T., Rijs A.J., De Vries-Hospers H.G., Meis J.F. Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998. J. Clin. Microbiol. 2002, 40:2648-2650.
36. Verweij P.E., Snelders E., Kema G.H., Mellado E., Melchers G.H. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?. Lancet Infect. Dis. 2009, 9:789-795.
37. van der Linden J.W., Snelders E., Kampinga G.A., Rijnders B.J., Mattsson E., Debets-Ossenkopp Y.J., Kuijper E.J., Van Tiel F.H., Melchers W.J., Verweij P.E. Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. Emerg. Infect. Dis. 2011, 17:1846-1854.
38. van der Linden J.W., Camps S.M., Kampinga G.A., Arends J.P., Debets-Ossenkopp Y.J., Haas P.J., Rijnders B.J., Kuijper E.J., van Tiel F.H., Varga J., Karawajczyk A., Zoll J., Melchers W.J., Verweij P.E. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domestic homes. Clin. Infect. Dis. 2013, 57:513-520.
39. Walsh T.J., Anaissie E.J., Denning D.W., Herbrecht R., Kontoyiannis D.P., Marr K.A., Morrison V.A., Segal B.H., Steinbach W.J., Stevens D.A., van Burik J.A., Wingard J.R., Patterson T.F., Infectious Diseases Society of America Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 2008, 46:327-360.
40. Zhao Y., Stensvold C.R., Perlin D.S., Arendrup M.C. Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases. J. Antimicrob. Chemother. 2013, 68:1497-1504.